Blis Technologies in patent dispute with Bluestone Pharma

Blis Technologies is currently engaged in ongoing negotiations with Bluestone Pharma and Lactosan, following the discovery that Bluestone Pharma had filed patents for Blis' fermentation processes, which contained confidential information shared under a non-disclosure agreement.

The company said it became aware of the issue on Sept 24.

In response, Blis Technologies' senior executives travelled to Milan, Italy, for the CPHI Milan pharma conference, where they met with representatives from Bluestone Pharma and Lactosan to continue the negotiations.